Background Perineal wound morbidity is common following abdominoperineal excision of the rectum (APE). There is no consensus on the optimum perineal reconstruction method after APE, and in particular 'extralevator APE' (ELAPE).
Methods A systematic review of the PubMed, Embase and Cochrane databases was performed. This position statement formulated clinical questions and graded the evidence to make recommendations.
Results Perineal wound complications may be higher following ELAPE compared to 'conventional APE (cAPE)' however there is insufficient evidence to recommend cAPE over ELAPE with regards to the impact upon perineal wound healing. The majority of cAPE studies have used primary closure with varying complication rates reported. Where concerns regarding perineal wound healing exist, myocutaneous flap closure may be considered as an alternative method. There is minimal available evidence on perineal mesh reconstruction following cAPE. Primary closure, mesh use and myocutaneous flap reconstruction following ELAPE has been reported although variations in definitions and low-quality of available evidence limit comparison. There is insufficient evidence to recommend one particular method of perineal closure after ELAPE. Primary perineal closure is likely to have a higher risk of perineal herniation. Myocutaneous flaps and biological mesh have been effectively used in ELAPE closure. There is insufficient evidence to support one particular type of flap or mesh. Perineal wound complication rates are significantly increased when neo-adjuvant radiotherapy is delivered, regardless of surgical technique. There is no evidence that laparoscopy reduces APE perineal wound complications.
Conclusion
This position statement updates clinicians on current evidence around perineal closure after APE surgery.
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Background
Perineal wound problems are a common complication following abdominoperineal excision of the rectum (APE). Miles' original description of APE [1] has recently been revisited to include division of the levator ani muscles at their origins, re-branded as 'extra-levator' APE (ELAPE) or 'cylindrical' APE. The oncological benefits of ELAPE compared with a 'conventional' technique for APE (cAPE) remain debated [2, 3] , however the Association of Coloproctology of Great Britain and Ireland (ACPGBI) is aware of a significant level of interest in this technique both in the UK and globally. The UK low rectal cancer (LoREC) development programme [4] included cadaveric training courses to facilitate safe dissemination of this surgical technique [5] .
The ELAPE technique leaves a larger defect at the level of the pelvic floor that can present a challenge to reconstruct. Despite three recent systematic reviews on this subject [6] [7] [8] , there is still no clear consensus on the optimum method of closure of the perineal wound after APE and ELAPE particularly following chemoradiotherapy.
Aim and objectives
The aim of this position statement was to update the literature and where feasible, draw consensus on this subject to aid clinical decision making relating to perineal reconstruction during APE surgery for rectal adenocarcinoma. Specific objectives were: 1 To define whether ELAPE is associated with higher rates of perineal wound complications than cAPE 2 To perform an evidence synthesis exercise to develop recommendations for perineal wound closure after: a cAPE b ELAPE c Administration of neoadjuvant chemoradiotherapy d Reconstruction following a laparoscopic approach
Methodology
The approach adopted mirrored that of previous ACPGBI position statements [9] in that there was a standardised approach of: 1 formulating the clinical questions 2 searching for relevant evidence 3 grading the evidence 4 making relevant statements and or recommendations Searches of Medline, EMBASE and the Cochrane Databases were performed to identify relevant articles for consideration. The following search terms were used: ['Abdomino-perineal' OR 'APER' OR 'APER' OR ELAPE OR 'ELAPER'] AND ['reconstruction' OR 'flap' OR 'mesh']. Searches were limited to English language publications published between 1996 and 15 July 2016. Additional publications were retrieved from the references cited in articles identified from the primary search of the literature and also identified through input from the expert steering group membership. The first level search was performed by two authors (JF and ST). Relevant full text articles were identified and screened for inclusion. Publications were included in the evidence synthesis if they reported upon five or more patients and reported clinical outcomes relating to healing of the perineum after APE for rectal cancer. Studies were excluded if patients underwent extended (pelvic exenteration) surgery, intersphincteric resection, or were being treated for anal cancer, benign disease, recurrent disease or other non-rectal malignancies.
All evidence was classified according to an accepted hierarchy of evidence. In-keeping with the NICE and SIGN organisations, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used for classifying the quality of evidence and reporting the strength of recommendations [10] .
Quality of evidence

++++
High Quality -Further research is very unlikely to change our confidence in the estimate of effect +++ Moderate Quality -Further research is likely to have an important impact on our confidence in the estimate of effect which may change the estimate ++ Low quality -Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate + Very low quality -any estimate of effect is very uncertain
Strength of recommendation
↑↑
Strong recommendation for using an intervention ↑?
Weak recommendation for using an intervention ↓?
Weak recommendation against using an intervention ↓↓ Strong recommendation against using an intervention
In this study cAPE is defined as total mesorectal excision down to the pelvic floor then perineal dissection performed from below through the levator muscles in a plane outside the anal sphincter complex with ELAPE defined as a wide resection of the levator ani muscles at their origins, leaving a larger defect at the level of the pelvic floor [11] .
Reported outcomes relating to the perineum varied across the included studies, with definitions of postoperative perineal complications including non-healing, infection, wound breakdown, and dehiscence. In-keeping with previous reviews of this subject, we pooled these complications under the group heading 'perineal wound complications,' whilst acknowledging that this may represent a heterogeneous group due to reporting variation amongst studies. Except where specifically stated, short term outcomes are defined as 30 days post-surgery. Where reported, rates of perineal hernia development were extracted. To facilitate comparison, other outcomes including length of stay and mortality were extracted, as well as demographic information, details of neo-adjuvant radiotherapy and operating time.
For myocutaneous flap reconstruction, rates of flap necrosis and of short term donor-site morbidity were also extracted.
Results
The literature search identified 319 individual citations from MEDLINE, 736 from EMBASE and none from the Cochrane database. After review of titles and abstracts, 94 full text publications were obtained for review. Two further publications were identified through input from the steering group. A total of 45 studies were identified for inclusion.
Recommendations
Findings
Complications of perineal wound healing are common following APE surgery. A consensus of what constitutes a complication has not been clearly defined in the literature, with outcomes reported in published studies including infection, abscess formation, dehiscence, sinus formation and development of a perineal hernia. Some studies only reported severe complications or where intervention was required, whereas others reported more comprehensively. The timeframe involved in capturing these post-operative complications is also poorly defined (+)
Recommendation
Surgeons should ensure that there are robust multidisciplinary post-operative and outpatient care pathways in place given the frequency of perineal complications reported following APE. (↑↑) Perineal wound morbidity: ELAPE vs 'conventional' APE Although the original APE description included wide resection of the levator muscles, for most of the late 20th century the conventional method used for APE involved performing mesorectal excision down to the pelvic floor then perineal dissection performed from below through the levator muscles in a plane outside the anal sphincter complex. With such a resection a variable amount of levator musculature remains at the level of the pelvic floor. There is a perceived greater risk of complications after ELAPE as the perineal surface wound is larger, as is the size of the tissue defect at level of the pelvic floor. However, only a small number studies have directly compared outcomes between cAPE and ELAPE techniques.
Two small randomised controlled trials (RCTs) have compared ELAPE with cAPE [12, 13] with neither reporting a significant difference in wound complications rates between, although this was not the primary endpoint of either study. It is noted that chronic perineal pain was noted to occur significantly more frequently after ELAPE (51% vs 6%, P < 0.001) [12] . Three large multi-centre [14] [15] [16] and three single-centre observational studies [17] [18] [19] were identified comparing outcomes after ELAPE and cAPE. Results are summarised in Table 1 .
Following the UK LoREC National Development Programme [4] a voluntary database was set up to record outcomes following APE. Jones reported outcomes from 172 ELAPE procedures and 94 cAPE procedures from 42 units with ELAPE not showing any increased perineal wound morbidity (30% ELAPE vs 31% cAPE) [15] . Omentoplasty was performed in 20% of ELAPE and 7% of APE patients but was not used or reported by all other included studies.
Asplund conducted a study in which all 1373 patients who underwent APE in Sweden between 2007 and 2009 were identified [14] . All surviving patients were contacted and asked to complete a detailed questionnaire asking about their post-operative recovery. Five hundred and forty five patients returned completed questionnaires, however the method of APE (ELAPE or cAPE) was only available for 284. Delayed perineal wound healing (≥ 4 weeks) was reported in 25% and was more common after ELAPE (32% vs 11%, P < 0.001). However, this did not translate into a larger number of long-term perineal symptoms amongst ELAPE patients compared with cAPE, with 50% of all patients reporting perineal symptoms 3 years after surgery.
The multicentre observational study by West compared outcomes in 176 patients from eleven European centres undergoing ELAPE with 124 patients undergoing cAPE from a single UK centre [16] . Significantly higher rates of perineal wound complications were reported amongst the ELAPE group (38% vs 20%, P = 0.009). Patients in the ELAPE group included primary closure, mesh and myocutaneous flap reconstruction techniques. This is the only study where objective pathological confirmation was obtained to verify that an ELAPE procedure had been performed.
Findings
Perineal wound complications might be higher following ELAPE compared with conventional APE, however the published evidence is inconclusive at present. A lack of quality assurance reporting to confirm the extent of ELAPE resection limits the generalisability of published results. Although data is available from RCTs comparing these techniques, these studies have been small and were not designed to address this specific clinical question. (++) Recommendation APE techniques (cAPE/ELAPE) are not clearly defined in literature, limiting any conclusion on the associated risks of perineal wound complications.
Conventional APE -Management of the perineal wound
In the studies reported above, patients in the cAPE group underwent primary closure of the perineal wound, and indeed this has generally been the preferred method of managing the perineal wound amongst the majority of surgeons following cAPE. Reported rates of perineal wound morbidity following cAPE with primary closure vary widely between individual series, with some reporting perineal wound complication rates as high as 50% [20, 21] .
Touny conducted a single centre RCT randomising 60 patients that received neo-adjuvant long-course chemoradiotherapy (CRT) to either primary closure of the perineum or vertical rectus abdominus myocutaneous (VRAM) flap reconstruction after cAPE. Significantly higher rates of wound infection, abscess, delayed healing or wound dehiscence were reported amongst the primary closure group (46.6% vs 17.2%, P = 0.015) [22] . This result is subject to performance and detection bias due to the inability to blind the surgeon and assessors. Of note, donor site morbidity was not reported in this trial. The National Surgical Quality Improvement Programme (NSQIP) national database was used to identify patients undergoing APE from 435 American institutions between 2005 and 2013 [23] . Patients were divided into cohorts who had flap closure (n = 527) or no flap (n = 6678). The overall rate of wound complications was 25% in the flap cohort (vs 21%, P = 0.054), however significantly higher wound dehiscence rates were reported in the flap cohort (7% vs 3%, P < 0.001). Although generalizable, data from such a large database is likely to be heterogeneous and the observed differences may be attributable to confounding factors or to patient selection.
The literature search identified six single-centre observational studies reporting on patients in whom myocutaneous tissue flaps were used to reconstruct the perineum following cAPE for rectal cancer [24] [25] [26] [27] [28] [29] . The majority used VRAM flaps, although flaps harvested from gluteal, gracilis, and latissimus dorsi muscles have been described. Overall perineal wound complication rates ranged from 13 to 50% with flap necrosis rates between 0 and 13% and donor site complication rates of 8-29%. A likely confounding factor in these studies was that patients who underwent selection for flap reconstruction may represent more complex wounds or had other factors expected to lead to poor healing. Studies reporting outcomes from myocutaneous flap reconstruction of the perineum after cAPE are summarised in Table 2 . Historically, the use of an absorbable synthetic mesh sutured at the pelvic inlet has been reported to exclude the small bowel from the pelvis, specifically to minimise radiation enteritis from adjuvant radiotherapy after cAPE [30] . However, the only recent study reporting mesh use at the level of the pelvic floor following cAPE was from the UK LoREC registry where biologic, polyester and absorbable vicryl were used in a small number of cases [15] .
Findings
The majority of available studies used primary closure of the perineum following cAPE, with widely varying rates of reported wound complications. A small number of studies have reported the use of flaps, including an RCT which demonstrated significantly lower perineal wound complication rates when a myocutaneous flap was used compared with primary wound closure. Mesh has rarely been used to facilitate perineal wound closure following cAPE. (++)
Recommendations
Primary closure of the perineum has been widely used following cAPE. (↑↑)
Where concerns regarding perineal wound healing exist, myocutaneous flap closure may be considered as an alternative method. (↑?) 
ELAPE
If a complete resection of the levator muscles is performed, as per Holm's description of the ELAPE technique [31] , the only remaining native tissue left available to close the defect is the skin, subcutaneous tissues, and ischio-rectal fat. Primary closure alone of these remaining tissues has been reported, however alternative methods of perineal reconstruction include the use of a mesh or tissue flap to facilitate wound closure.
RCT evidence
The BIOPEX randomised controlled trial was a multicentre study involving 104 patients undergoing ELAPE who were randomly assigned to primary closure (n = 54) or biologic mesh closure (n = 50) [11] . The primary endpoint was uncomplicated perineal wound healing at 30 days post-operatively. All but one patient received neo-adjuvant radiation therapy. Uncomplicated perineal wound healing at 30 days was seen in 66% of patients after primary closure and in 63% of patients after mesh reconstruction (P = 0.72). A post-hoc multivariable analysis corrected for baseline differences between the groups did not reveal any significant association between uncomplicated perineal wound healing and the closure method or use of omentoplasty. The perineal hernia rate at 1 year was 27% after primary closure compared with a significantly lower rate of 13% in the biologic mesh group (P = 0.032). Post-operative length of stay and post-operative complication rates did not differ significantly between the two arms. Quality of life was evaluated using two validated questionnaires with no significant differences were observed between the groups. To date no randomized controlled trials have been published comparing myocutaneous flap reconstruction with mesh closure of the perineum following ELAPE.
ELAPE -Primary perineal wound closure
Primary closure of the perineal wound after ELAPE has been reported in four studies containing 345 patients [11, 19, 32, 33] . Outcomes from these studies are summarised in Table 3 . Published rates of perineal wound complications range from 8 to 44%. Where reported, the average perineal hernia rate was 10%. Shen reported perineal wound complications in 8% of 36 patients who underwent primary closure of the perineum after ELAPE [19] . Bebenek described a single-centre series of 210 patients over a 10 year period in which the perineal wound was closed primarily following placement of a perineal drain [33] . Overall perineal wound complication rates were 18% with a 1% perineal hernia rate.
Sayers and colleagues reported upon a consecutive 5-year ELAPE cohort of 54 patients of whom 46 patients had primary closure of their perineal wounds [32] . Perineal herniation was identified in 14 (26%) patients with a median interval to diagnosis of 10.5 months.
ELAPE -Mesh closure
Following ELAPE, a sheet of mesh can be sutured to the insertions of the excised levator muscles to close the tissue defect at the level of the pelvic floor. Such a mesh can provide support and is intended to reduce the risk of perineal herniation of the abdominal viscera. Biologic mesh has been preferred to synthetic materials as the small bowel will sit in the contact with the mesh. The perineal skin is closed over the mesh, often with temporary suction drainage to reduce the build-up of seroma.
Fifteen studies were identified through the literature search [11, 12, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] , reporting on 451 patients who underwent mesh reconstruction of the perineum following ELAPE, including 81 patients from two RCTs that compared mesh with primary closure [11, 12] . Results of these studies are summarised in Table 4 . In three studies, reporting on 130 patients, human acellular dermal matrix was used [12, 39, 45] ; whereas the remaining 12 studies of 321 patients, porcine dermal collagen mesh was used. This is in itself a heterogeneous group, as different porcine biologic mesh products were used in different studies, and these may vary in their properties. No studies directly compared one particular mesh with another. In these fifteen studies omentoplasty was performed in only 61 patients. Wound complication rates in individual series varied from 0 to 50%. It is however difficult to retrieve an accurate true rate as the definition and classification of complications varied between studies. Average length of stay was 9 days. Six studies reported rates of mesh explantation, with an average rate of 1.8%. Lower rates of perineal herniation were seen compared to primary closure as eight mesh studies reported no herniation with three series [39] . Perineal reconstruction was by primary closure (n = 19) or human acellular dermal matrix biologic mesh (n = 83). The overall rate of perineal wound complication rates was 24% and significantly lower in the biological mesh group compared with the primary closure cohort (P = 0.006).
ELAPE -Myocutaneous flap closure
Transposition of the patient's native tissues offers an attractive method for filling the tissue defect left following ELAPE. Three main flap types have been reported based around rectus abdominus, gracilis and gluteus maximus muscles. The muscle component of the flap provides support at the level of the excised levators, whereas the use of an overlying skin paddle brings native non-irradiated tissue into the cutaneous wound which may facilitate healing. The literature search identified 13 studies, reporting upon 414 patients, in whom a myocutaneous tissue flap was used to facilitate perineal wound closure following ELAPE [2, 13, 16, 18, 20, 31, 44, [47] [48] [49] [50] [51] [52] [53] . The results of these studies are summarised in Table 5 .
Wound complication rates in individual series ranged from 0 to 50%, although this represents a heterogeneous group of different flaps and reconstruction techniques. Eleven studies reported flap necrosis rates, which ranged between from 0 to 11%. Perineal herniation was reported in four studies (with varying definitions and follow up length & modality) and varied between 0 and 21%. Donor site morbidity was reported in just six of the studies, with reported rates ranging between 0 and 11%. No study directly compared one type of flap with another type. Two small studies performed omentoplasty in all patients (n = 37) otherwise this technique was not utilised by the flap studies.
The multicentre observational study by West showed no differences in perineal wound complication rates amongst 80 patients whom underwent flap reconstruction following ELAPE when compared with 78 patients whom underwent primary closure of the perineum (n = 67) or biologic mesh placement (n = 11) (33% vs 43%, P = 0.239) [16] . It is however noted that the method used for perineal wound closure was not known for an additional 18 patients in this study. No other studies were identified that compared flap reconstruction with primary closure following ELAPE.
Foster and colleagues performed a systematic review of the published literature up to November 2011 comparing complication rates between biologic mesh and myocutaneous flap reconstruction of the perineal wound [6] . This study identified eleven observational studies reporting outcomes from 255 patients undergoing flap repair and 85 undergoing biologic mesh reconstruction. Data was pooled for each of the reconstruction methods, and no significant differences were observed between the two methods in terms of perineal wound complication rates or rates of perineal hernia formation (P = 0.67).
Christensen retrospectively compared outcomes from their unit across two time periods with fasciocutaneous flap used in first period (n = 33), and biologic mesh used in second (n = 24) [44] . The rate of perineal hernia in was 21% in the flap cohort compared with 0% in the mesh group (P < 0.01). Perineal wound complications occurred in 6% of patients who had flap reconstruction and in 17% of those who had mesh. The median length of stay was significantly shorted following mesh repair compared with flap closure (9 vs 14 days, P < 0.05).
In the study authored by Asplund, 222 surviving patients who underwent APE completed a detailed questionnaire [14] . Primary closure and flap reconstruction were both found to increase the risk of severe perineal morbidity compared with mesh reconstruction of the perineum.
Peacock compared a consecutive series of 10 patients who underwent biologic mesh repair after ELAPE at their centre with an earlier cohort of five patients who underwent VRAM flap reconstruction of the perineum following ELAPE [42] . The median operating time was significantly longer in the VRAM group and the median length of post-operative stay was 20 days for VRAM and 10 days for mesh (P = 0.067). Median cost for the care episode was £11 075 for the VRAM cohort compared with £6513 for the mesh cohort (P = 0.0097). Rates of early post-operative complications did not differ between the two groups.
Findings
Primary perineal wound closure following ELAPE has been reported and appears to be feasible. Published perineal wound complication and hernia rates ranged from 8-44% and 1-27% respectively. (++) Biologic mesh has been used in a number of studies to reconstruct the perineal defect after ELAPE. Published perineal wound complications after ELAPE with biologic mesh closure of the perineum ranged from 0-50% with low rates of herniation. There are no studies comparing one particular type of biologic mesh with another. (+++) Myocutaneous flaps have been used in a number of studies to reconstruct the perineum following ELAPE with wound complication rates ranging from 0-50%. No study has compared one type of flap against another type. (++)
The only published large multi-centre RCT in this field found similar rates of perineal wound complications with mesh compared with primary closure, however rates of perineal hernia were significantly higher at one year when primary closure was employed. (+++)
Recommendations
There is insufficient published outcome data comparing flap and mesh closure to recommend one over the other. We advocate a personalised approach to each patient when deciding upon the method of perineal wound reconstruction following ELAPE. Decisions regarding what method should be employed should include consideration of surgical expertise, morbidity, cost-effectiveness, and the size of the defect that needs to be filled. 
Impact of radiotherapy upon method of perineal closure
Neo-adjuvant radiotherapy improves local control in patients with rectal cancer but may affect perineal wound healing [54] . Radiation can damage adjacent normal tissues, resulting in apoptotic cell death, a release of pro-inflammatory cytokines, and increased vascular permeability [55] . As a result, this acute inflammatory response can impair normal wound healing processes.
Data from the voluntary UK national APE registry reported ELAPE (n = 172) and cAPE (n = 94) procedures from 42 units [15] . Although rates of wound breakdown were similar for both ELAPE and cAPE, the determining factor in both groups was neoadjuvant therapy: following radiotherapy the rate of break down was 38% compared with 16% (P = 0.0003).
Musters performed a systematic review looking at perineal wound healing following APE [8] . They found neo-adjuvant radiotherapy significantly increase the risk of perineal wound problems after both cAPE and ELAPE. Following cAPE without neo-adjuvant radiotherapy the pooled overall perineal wound problem rate was 15.3% compared to 30.2% after neo-adjuvant radiotherapy (P = 0.0003). Perineal wound problems occurred in 14.8% of patients after ELAPE without neo-adjuvant treatment and in 37.6% of those who had ELAPE and neo-adjuvant radiotherapy.
Whilst the impact of radiotherapy upon perineal wound healing is acknowledged, there is insufficient evidence at present to ascertain whether the use of a biologic mesh or tissue flap as an adjunct to perineal wound closure improves wound healing following radiotherapy.
Findings
Perineal wound complication rates are significantly increased when neo-adjuvant radiotherapy is delivered, regardless of whether a cAPE or ELAPE technique is employed. (+++)
Recommendation
Impaired perineal wound healing should be expected following neo-adjuvant radiation therapy.
At present there is insufficient evidence to recommend one particular method of perineal closure over another following neo-adjuvant radiotherapy.
Impact of approach to surgery: Laparoscopic vs open APE
The national bowel cancer audit shows the majority of UK colorectal cancer patients now receive minimally invasive surgery, the role of minimally invasive surgery in the management of rectal cancer remains contentious. The recent American ASOCOG Z6051 and Australasian ALaCART RCTs failed to show non-inferiority of a laparoscopic approach and concluded that such an approach for rectal cancer resection cannot be supported [56, 57] however other multi-centre RCTs have demonstrated equivalent outcomes [58, 59] . The majority of patients within these trials underwent anterior resection and anastomosis and the results cannot be considered as directly applicable for patients requiring APE surgery. Additionally, none of these trials specifically reported upon perineal wound outcomes. In a single-centre RCT comparing laparoscopic and open approaches to APE in which the perineum was closed primarily and no patients received neoadjuvant treatments, no difference in wound infection rates were seen [60] .
Two systematic reviews and meta-analyses comparing laparoscopic to open approaches for APE are available although the primary endpoints of both did not address the question of perineal wound healing. Eight publications containing 454 cases were included in the analysis by Ahmad with early morbidity and perineal wound complications forming secondary endpoints [61] . Although the perineal closure techniques and use of neoadjuvant therapy varied, no difference between laparoscopic or open APE was seen in rates of early perineal wound complications (P = 0.556) nor in associated surrogate measures of recovery. When analysed by design, no differences were seen in the randomised and non-randomised studies. The authors concluded that the equal perineal wound complication rates observed explained why minimal invasive surgery did not lead to shorter hospital stays. A pre-defined APE subgroup analysis was performed within an earlier meta-analysis of laparoscopic vs open rectal cancer surgery [62] . No significant differences in perineal wound complications were seen between the groups in the five studies reporting this outcome (22.8% vs 16.2%, OR 1.03).
There are limited reports where a laparoscopic abdominal approach has been applied when performing an ELAPE resection. Vaughan-Shaw et al. performed a small prospective case control study comparing laparoscopic APE and ELAPE with open APE [63] . A nonsignificant difference in perineal complications was seen in this small study with more ELAPE patients experienced perineal wound complications (12.5%, 50%, 20%, P = 0.21) [41] . In a single centre laparoscopic ELAPE prospective, homogenous series of 28 patients, where biological mesh reconstruction and layered closure was performed, 25% of patients developed perineal complications [36] . These accounted for 58% of all identified complications and five (18%) hospital readmissions with three patients requiring re-operation (11%). At 6 week follow up, 21% had signs of perineal infection.
In the absence of dedicated studies, surgeons should consider whether VRAM flap reconstruction following laparoscopic abdominal approach is appropriate as this may negate some of the potential patient benefits of minimal access surgery.
Findings
Perineal wound complications are common irrespective of surgical approach undertaken. There is no current evidence that minimally invasive surgery reduces APE perineal wound complications, and no data comparing methods of reconstruction following a laparoscopic approach to APE. (++)
Recommendations
There is insufficient evidence currently exists to support a particular method of perineal wound closure following laparoscopic approach to APE
Discussion
There is limited data at present to support strong recommendations relating to closure and management of the perineal wound following APE. The majority of available studies are single-centre retrospective series with differing definitions and classifications of perineal wound complications.
A personalised approach to each patient is advocated when deciding upon the method of perineal wound reconstruction following APE. Individual requirements to ensure appropriate margins should be addressed with acknowledgement of the benefits and risks of each modality. For smaller perineal wounds, where sufficient muscle remains to bridge the pelvic floor, it would seem reasonable to close the tissues primarily. Following cAPE, primary closure has traditionally been employed and this seems an appropriate approach, with myocutaneous flaps an alternative option although the particular indications for this have not been clearly defined. Where a surgeon has performed a more extensive ELAPE procedure, options for managing the perineum include a biologic mesh, a myocutaneous flap, or primary closure of the tissues. Whilst published rates of wound complications are broadly similar for the different techniques, this data should be interpreted with caution as it is difficult to retrieve a true rate as the definition and classification of complications varies between studies with a notable absence of long term data.
Many surgeons personalise each APE procedure based upon the pre-operative MRI. Although we have made a distinction between ELAPE and cAPE procedures, possibly as a result of our search string, few of the included papers commented on variation within their study. The frequency, extent and impact of factors such as patient positioning, levator ani or posterior vagina en-bloc excision are not known and represent a limitation of this study. Objective quality assurance mechanisms such as patient, operative or specimen imaging performed were rarely utilised to qualify the extent of resection. Tumour details and pre-operative radiological and endoscopic data and their subsequent impact upon surgical decision making were infrequently reported by the included studies and represents a key omission. This heterogeneity limits the generalisability of the evidence presented in this position statement. Furthermore, the retrospective design of the majority of studies included in this review represents a further source of inaccuracy. Similarly, length of stay data could be indicative of the differences between individual health and social care service systems rather than an inherent consequence of the type of surgery performed.
Decisions regarding mesh or flap use following a more extensive resection should include consideration of surgical expertise, morbidity, cost-effectiveness, and the size of the defect. Whilst a mesh bridges the defect in the pelvic floor without adding tissue, a flap is able to also fill 'dead space' when a larger perineal soft tissue defect has been created. There is a single multi-centre RCT addressing the question of perineal wound management after ELAPE [11] . This compared biologic mesh vs primary closure of the perineal tissues following ELAPE, and whilst wound complication rates did not significantly differ between the arms, the rate of perineal hernia at 1-year post-operation was significantly higher in those patients undergoing primary perineal wound closure. This review has further highlighted that there remains no agreed classification, methodology or timepoint for assessing for perineal herniation and importantly patient reported outcome data is surprisingly absent.
Whilst the use of laparoscopic techniques for rectal cancer resection remains contentious, there is currently no evidence that minimally invasive surgery affects APE perineal wound complications, and no data specifically comparing methods of reconstruction following a laparoscopic approach to APE. There is clear evidence that radiotherapy increases the risk of perineal wound complications following both cAPE and ELAPE, however how this affects decisions relating to reconstruction of the perineum has not been clearly defined. No comparison between SCRT and CRT outcomes were identified.
There is a strong need for further, dedicated, multicentre prospective studies with standardised objective definitions of procedures and outcome measures in order to clarify the optimal approach to management of the perineum following APE, and in particular ELAPE. Given the paucity of patient reported data following APE surgery we call for this to be incorporated into all future study designs. Investigators should incorporate strategies to ensure variation in the interventions delivered are recorded. Randomised trials also appear justified on this topic given the many areas of equipoise identified in this review.
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